NuVasive To Expands Global Presence, Pediatric Portfolio With Ellipse Buy
This article was originally published in Clinica
On Jan. 5, NuVasive said it agreed to buy Ellipse in a deal that is expected to be complete by the end of February. NuVasive will pay an additional $30 million in 2017 if Ellipse's portfolio meets certain revenue targets.
Register for our free email digests: